Med List Week One

Drug Ordered Route, Dose, Frequency ---------------------------Generic Name Plavix PO, 75mg, QD

Classification ---------------------------------Possible Routes of Administration Anti-coagulant

Clopidogrel Bisulfate

PO

Pepcid PO, 20mg, BID

Antiulcer (H2 blocker)

Famotidine

PO, IV

Levaquin IV, 500mg, QD

Fluoroquinolone Antimicrobial

Levofloxacin

PO, IV

Flagyl PO, 500mg, TID Metronidazole

Antiprotozoal PO, IV

Actions and Uses For Your Patient

Major Side Effects

Initial 300mg loading dose, then 75mg daily.

Anticoagulant; to reduce thrombolytic events

Rash, Hemorrhage, Headache, Dizziness, Fatigue, GI upset

Monitor PT, CBC. Use cautiously with NSAIDS or aspirin. Tell patient it may take longer than normal to stop bleeding. Advise MD of unusual bleeding or bruising occurs. Teach patient may take several days for drug to leave system.

N/A

20mg PO BID

Decrease gastric acid secretion

Headache, fever, dizziness, vertigo, diarrhea, anorexia, tinnitus

N/A

500mg once daily (in 100 ml)

To treat Urinary tract infection

headache, dizziness, tinnitus, insomnia, shakiness, changes in vision, seizures

500mg PO TID

To treat Clostridium difficile

Headache, nausea, vaginitis, V/D, Constipation, Dry mouth, Metallic taste, abdominal pain

Assess for abdominal pain. Assess for blood in emesis, stool, or gastric aspirate. Check kidney and liver function. Obtain specimen for C& S before starting therapy. Monitor for CNS changes. Monitor glucose and renal, hepatic, and hematopoetic blood studies. Administer with meals, Record number and character of stools. Monitor liver function tests carefully in elderly. Tell patient to avoid alcohol. Use cautiously in patients with CNS disorder and those with visual changes

1

Nursing Implications

IV Rate of Administ ration

Usual Dosage

Give over 60 minutes 1.7 or 2ml/min

N/A

Drug Ordered Route, Dose, Frequency ---------------------------Generic Name Namenda PO, 10mg, BID Memantine hydrochloride

Classification ---------------------------------Possible Routes of Administration CNS Drug (Anti-alzheimer) PO

Coumadin PO, 6mg, QD Warfarin sodium

Anticoagulant

Heparin IV, 25000 units/500 ML of D5W, Daily

Anticoagulant

PO,IV

IV, SC

Usual Dosage

Actions and Uses For Your Patient

Major Side Effects

Nursing Implications

Monitor kidney function, use cautiously in patients with an increased urine pH, use cautiously in patients with history of seizures or hepatic impairment Use cautiously in patient with colitis, Draw blood to establish baseline coagulation parameters before therapy. Monitor PT and INR. Give at same time daily. Regularly inspect for bleeding gums, bruises on arms or legs, nosebleeds, melena, hematuria, hematemesis, tarry stools Draw blood to establish baseline coagulation parameters before therapy. Monitor platelet count regularly. Monitor PT and INR. Give at same time daily. Regularly inspect for bleeding gums, bruises on arms or legs, nosebleeds, melena, hematuria, hematemesis, tarry stools.

10mg BID

To improve symptoms related to Alzheimer’s disease

Aggressiveness, agitation, anxiety, confusion, headache, anorexia, constipation, N/V/D,CVA, heart failure

2- 5mg PO daily for 24 days, then dosage based on PT and INR; usual dose 210mg PO daily

To treat deep vein thrombosis

Fever, diarrhea, rash, hemorrhage, hepatitis, headache, anorexia, N/V, cramps, mouth ulcerations, sore mouth, hematuria

Initially 5,000 units by IV bolus, then 750-1500 units/hr by IV infusion

To treat DVT

Fever, rhinitis, hemorrhage, overly prolonged clotting time, thrombocytopenia, white clot syndrome, hematoma, pruritis

2

IV Rate of Administ ration N/A

N/A

16ml/hr

Drug Ordered Route, Dose, Frequency ---------------------------Generic Name Megace PO, 400mg, BID

Classification ---------------------------------Possible Routes of Administration Antineoplastic

Megestrol acetate

PO

Toprol XL PO, 25mg, QD Metoprolol succinate

Antihypertensive (Beta blocker) PO, IV

Usual Dosage

Actions and Uses For Your Patient

480-600 mg daily

To treat anorexia

50-100

Prevents myocardium from ischemia d/t atheroscleroti c heart disease

3

Major Side Effects

Weight gain, Thrombophlebitis, N/V/D, constipation, dry mouth, rash, hypertension Fatigue, dizziness, hypotension, depression, bradycardia, heart failure, AV block

Nursing Implications

IV Rate of Administ ration

Monitor for thromboembolus, Monitor glucose level, Monitor weight gain

N/A

Always check patient’s apical heart rate before giving drug: if less than 60 hold dose. Check BP frequently. Do not stop abruptly. May mask signs of hypoglycemia and hyperthyroidsim

N/A